Page last updated: 2024-10-26

brl 42810 and HIV

brl 42810 has been researched along with HIV in 2 studies

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research Excerpts

ExcerptRelevanceReference
"Lamivudine resistance has been found to confer cross-resistance to some of these compounds and it is likely that resistance to newer antivirals may also develop during prolonged use."2.41Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation. ( Delaney, WE; Locarnini, S; Shaw, T, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seehofer, D1
Rayes, N1
Berg, T1
Neuhaus, R1
Müller, AR1
Hopf, U1
Bechstein, WO1
Neuhaus, P1
Delaney, WE1
Locarnini, S1
Shaw, T1

Reviews

1 review available for brl 42810 and HIV

ArticleYear
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Antiviral chemistry & chemotherapy, 2001, Volume: 12, Issue:1

    Topics: 2-Aminopurine; Adenine; Amino Acid Sequence; Animals; Anti-HIV Agents; Antimetabolites; Antiviral Ag

2001

Trials

1 trial available for brl 42810 and HIV

ArticleYear
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 2000, Volume: 13, Issue:4

    Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; HIV;

2000